Revised tumor and node categorization for rectal cancer based on surveillance, epidemiology, and end results and rectal pooled analysis outcomes
about
Neoadjuvant Rectal (NAR) Score: a New Surrogate Endpoint in Rectal Cancer Clinical TrialsMultimodal imaging evaluation in staging of rectal cancerExpert opinions and scientific evidence for colonoscopy key performance indicatorsTNM staging of colorectal cancer should be reconsidered by T stage weightingAnal carcinoma: impact of TN category of disease on survival, disease relapse, and colostomy failure in US Gastrointestinal Intergroup RTOG 98-11 phase 3 trial.Analysis of stage and clinical/prognostic factors for colon and rectal cancer from SEER registries: AJCC and collaborative stage data collection system.Revised TN categorization for colon cancer based on national survival outcomes data.TRAP1 protein signature predicts outcome in human metastatic colorectal carcinoma.Capecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: surgical end points from National Surgical Adjuvant Breast and Bowel Project trial R-04The combination of early treatment response and ypT stage is a novel metric to stage rectal cancer patients treated with neoadjuvant chemoradiotherapy.Prognostic nomograms for predicting survival and distant metastases in locally advanced rectal cancersHepatocellular carcinoma: consensus recommendations of the National Cancer Institute Clinical Trials Planning Meeting.Is the prediction of prognosis not improved by the seventh edition of the TNM classification for colorectal cancer? Analysis of the surveillance, epidemiology, and end results (SEER) database.Interleukin-24 is correlated with differentiation and lymph node numbers in rectal cancer.May CTC technologies promote better cancer management?Increased number of negative lymph nodes is associated with improved cancer specific survival in pathological IIIB and IIIC rectal cancer treated with preoperative radiotherapy.Molecular profiling of colon tumors: the search for clinically relevant biomarkers of progression, prognosis, therapeutics, and predispositionPrognostic Significance of Lymph Node Ratio in Stage III Rectal Cancer.Lymph node harvest in colon and rectal cancer: Current considerationsPrognostic value of lymph node ratio in survival of patients with locally advanced rectal cancer.Lymph node count after preoperative radiotherapy is an independently prognostic factor for pathologically lymph node-negative patients with rectal cancerEffect of Lymph Node Count on Pathological Stage III Rectal Cancer with Preoperative Radiotherapy.Quantitative detection of the tumor-associated antigen large external antigen in colorectal cancer tissues and cells using quantum dot probe.TNM Staging of Colorectal Cancer Should be Reconsidered According to Weighting of the T Stage: Verification Based on a 25-Year Follow-Up.Prognostic impact of the metastatic lymph node ratio on survival in rectal cancerSelecting patients with locally advanced rectal cancer for neoadjuvant treatment strategies.Future directions in combined modality therapy for rectal cancer: reevaluating the role of total mesorectal excision after chemoradiotherapyAssessment of Serosal Invasion and Criteria for the Classification of Pathological (p) T4 Staging in Colorectal Carcinoma: Confusions, Controversies and CriticismsPreoperative endoscopic localization of colorectal cancer and tracing lymph nodes by using carbon nanoparticles in laparoscopyTime to lowest postoperative carcinoembryonic antigen level is predictive on survival outcome in rectal cancerPositron emission tomography/computed tomography for optimized colon cancer staging and follow up.Adjuvant treatment may benefit patients with high-risk upper rectal cancer: A nomogram and recursive partitioning analysis of 547 patients.High levels of serum platelet-derived growth factor-AA and human epidermal growth factor receptor-2 are predictors of colorectal cancer liver metastasisThe survival and clinicopathological differences between patients with stage IIIA and stage II rectal cancer: An analysis of 12,036 patients in the SEER database.Toward the non-surgical management of locally advanced rectal cancer.Definition of patients presenting a high risk of developing peritoneal carcinomatosis after curative surgery for colorectal cancer: a systematic review.A nodal positivity constant: new perspectives in lymph node evaluation and colorectal cancer.Role of pelvic exenteration in the management of locally advanced primary and recurrent rectal cancer.Serosal surfaces, mucin pools, and deposits, oh my: challenges in staging colorectal carcinoma.Can the new American Joint Committee on Cancer staging system predict survival in rectal cancer patients treated with curative surgery following preoperative chemoradiotherapy?
P2860
Q26796253-ADB66A74-F99B-42CD-A055-78B9B0640BE4Q26992282-E20797E3-D3A2-4E3E-869D-7C15CA29443BQ28078507-39BC0D7D-5CAF-4826-A23D-85D5EB6685BDQ28658050-776B6482-8B3A-4ECD-8759-80E6B7DC251AQ30409533-1A6479C9-9A02-4B50-920F-322082FEB155Q30870757-C70381B3-DB8D-48DB-995B-34127CFDA764Q33516922-FFEAB875-DBBF-432E-92C1-0930FF3EA9D4Q33591480-5617D177-9D54-480F-88C8-1327B361F826Q33729092-1322FE66-C2D5-4DAD-9EDF-FABBC02EAE7FQ33914174-74A552A1-599C-445F-860C-EA3774D93C07Q34110610-DF264E11-BA51-4238-B1E0-F6EF19491B37Q34131801-84AD860F-A2C7-4CC8-BC84-69954BB62156Q34333202-D6FCCBB7-0C13-4208-ADAF-09272D8ADEEBQ34717408-43856618-0693-42CD-8D29-31D6A9E080A2Q35016353-FC6F3842-62B6-4A9D-8DF8-33376DECA178Q35068085-B6DE3877-CCDE-4966-AE00-953192F3E415Q35246828-CB53C799-6F62-47AE-9F0A-E54CFBB01CF2Q35555663-854B116E-584E-4A0F-A1BE-7B5E8FCDA120Q35752056-6D48F0C3-5453-4821-9B30-1DC3441FB9E3Q35883107-BB2ACCA7-0B3D-4C28-A28D-B6BEDB884DBBQ36151978-AF2DBE70-0876-4AE7-BADD-A6EDF8B32B35Q36297989-5A7FBC11-4F75-445D-A945-9FFC61D5D35AQ36473528-131E4440-8915-4E8F-A250-6B3CB3957ACEQ36580973-CC8D4BB4-E80E-4FCC-B516-0D08F27A3EECQ37010449-1D6F41C6-F938-4B60-B0EA-7D8C73D4551AQ37038486-2474B7AA-4D40-4F73-9BE8-671BF900AA98Q37106318-C383F1DC-6BF7-407E-8816-FF2CB73E9C53Q37129754-4190734B-C092-4F32-BC5F-8FB252818DABQ37216011-246C6DE6-91E5-4170-859F-BEA3724F3697Q37277871-0F811D89-AE16-4F47-9214-AF2214698098Q37641478-2F0F2087-535E-4B29-AFAB-410E9C0FB1BEQ37662382-15D1848D-1843-4321-A9EA-BE0EAD5AF926Q37662632-843632F6-95F9-4C1F-9E4C-C48C1D20060AQ37694845-62F29CD2-C73B-4DCD-A6A4-6F55A1545EBEQ37998384-6A8848F8-4F10-4672-BC15-BA911BC49A09Q38054557-42F7E7C6-6813-4785-94F7-85740EF016D4Q38067618-EBE78302-E4B6-4829-BEC5-37B211AFE054Q38190473-9DF5997F-A2C0-470A-BFC2-6086FA127133Q38308067-BB4293CE-7604-4993-937A-ADD00836E93DQ38464448-FCD8B075-FC71-4485-BF65-854D6328709D
P2860
Revised tumor and node categorization for rectal cancer based on surveillance, epidemiology, and end results and rectal pooled analysis outcomes
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Revised tumor and node categor ...... ectal pooled analysis outcomes
@ast
Revised tumor and node categor ...... ectal pooled analysis outcomes
@en
type
label
Revised tumor and node categor ...... ectal pooled analysis outcomes
@ast
Revised tumor and node categor ...... ectal pooled analysis outcomes
@en
prefLabel
Revised tumor and node categor ...... ectal pooled analysis outcomes
@ast
Revised tumor and node categor ...... ectal pooled analysis outcomes
@en
P2093
P2860
P356
P1476
Revised tumor and node categor ...... ectal pooled analysis outcomes
@en
P2093
Andrew Stewart
Daniel J Sargent
Frederick L Greene
John Milburn Jessup
Leonard L Gunderson
P2860
P304
P356
10.1200/JCO.2009.23.9194
P407
P577
2009-11-30T00:00:00Z